Celldex Therapeutics saw the highest growth of 1.99% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Celldex Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Celldex Therapeutics has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 67% grants. The United States(US), Japan(JP), Australia(AU), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Celldex Therapeutics is filings its patents. Among the top granted patent authorities, Celldex Therapeutics has 67% of its grants in United States(US) and 33% in Japan(JP).
Regeneron Pharmaceuticals and Amgen could be the strongest competitors for Celldex Therapeutics
Patents related to cell & gene therapy and rare diseases lead Celldex Therapeutics's portfolio
Celldex Therapeutics has the highest number of patents in cell & gene therapy followed by, rare diseases. For cell & gene therapy, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Inflammation related patents lead Celldex Therapeutics portfolio followed by inflammatory bowel disease, and fibrosis
Celldex Therapeutics has highest number of patents in inflammation followed by inflammatory bowel disease, fibrosis, lung cancer, and rheumatoid arthritis. For inflammation, nearly 9% of patents were filed and 7% of patents were granted in Q2 2024.
For comprehensive analysis of Celldex Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
